Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
3(33%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
7
78%
Ph phase_3
2
22%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(6)

Detailed Status

Completed6
Active, not recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (22.2%)
N/A7 (77.8%)

Trials by Status

completed667%
recruiting111%
active_not_recruiting222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9